Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis

التفاصيل البيبلوغرافية
العنوان: Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis
المؤلفون: GUARALDI, Giovanni, NARDINI, Giulia, BEGHETTO, Barbara, ESPOSITO, Roberto, Orlando G., Maddeddu G., Vescini F., VENTURA, Paolo, Campostrini S., Corradini E., Parise N., Solinas P., Calia G. M., Mura M. S., Caudarella R.
المساهمون: Ho D., Stevenson M., Guaraldi, Giovanni, Orlando, G., Maddeddu, G., Vescini, F., Ventura, Paolo, Campostrini, S., Corradini, E., Parise, N., Solinas, P., Calia, G. M., Mura, M. S., Nardini, Giulia, Beghetto, Barbara, Caudarella, R., Esposito, Roberto
بيانات النشر: Foundation for Retrovirology and Human Health
USA
Alexandria, VA
سنة النشر: 2004
المجموعة: Archivio della ricerca dell'Università di Modena e Reggio Emilia (Unimore: IRIS)
مصطلحات موضوعية: Alendronate, HIV, Osteopenia, Osteoporosis
الوصف: OOsteopenia and Osteoporosis are frequent complications of HIV infection and may be related with low trauma fractures. Gender differences, with an increased prevalence of osteoporosis in male patients, have been observed. We conducted a 104-week prospective, randomized, open-label study to evaluate the effects of alendronate, vitamin D, and calcium supplementation on bone metabolism and bone mineral density in patients with HIV infection. Interim analysis at 52 weeks is presented.
نوع الوثيقة: conference object
وصف الملف: STAMPA
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/isbn/9780966976854; ispartofbook:Program & Abstracts 11th Conference on Retroviruses and Opportunistic Infections; 11th Conference on Retroviruses and Opportunistic Infections; volume:not applicable; firstpage:103 (n 742); lastpage:103; http://hdl.handle.net/11380/594027Test
الإتاحة: http://hdl.handle.net/11380/594027Test
رقم الانضمام: edsbas.E154BF49
قاعدة البيانات: BASE